Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-028291
Filing Date
2020-09-24
Accepted
2020-09-24 18:50:49
Documents
1
Period of Report
2020-09-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 9283
  Complete submission text file 0001213900-20-028291.txt   10620
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Issuer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2311 SPARTAN TRAIL SUGAR LAND TX 77479
Business Address
Hallock Kenneth (Reporting) CIK: 0001806925 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39555 | Film No.: 201196417